Therefore, human malignancies with high TRAP1 level, including CRC, are characterized by a predominant glycolytic phenotype, whereas other human neoplasms characterized by low TRAP1 expression (i.e. ovarian, cervical and renal carcinomas) exhibit a predominant oxidative metabolism [15, 38, 39]. Here, TRAP1 is linked to neoplasm.